Treatment outcome for systemic chemotherapy for recurrent pancreatic cancer after postoperative adjuvant chemotherapy

Abstract Objectives A global consensus on how to treat recurrent pancreatic cancer after adjuvant chemotherapy with gemcitabine (ADJ-GEM) does not exist. Methods We retrospectively reviewed the clinical data of 41 patients with recurrences who were subsequently treated with chemotherapy. Results The...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2012-09, Vol.12 (5), p.428-433
Hauptverfasser:	Taniyama, Tomoko Katsui, Morizane, Chigusa, Nakachi, Kohei, Nara, Satoshi, Ueno, Hideki, Kondo, Shunsuke, Kosuge, Tomoo, Shimada, Kazuaki, Esaki, Minoru, Ikeda, Masafumi, Mitsunaga, Shuichi, Kinoshita, Taira, Konishi, Masaru, Takahashi, Shinichiro, Okusaka, Takuji
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvant chemotherapy Adult Aged Antigens Antimetabolites, Antineoplastic - therapeutic use Cancer therapies Chemotherapy Chemotherapy, Adjuvant Deoxycytidine - analogs & derivatives Deoxycytidine - therapeutic use Disease control Disease-Free Survival Endocrinology & Metabolism Female Gastroenterology and Hepatology Gemcitabine Hospitals Humans Male Medical prognosis Middle Aged Ovarian cancer Pancreatic cancer Pancreatic Neoplasms - drug therapy Pancreatic Neoplasms - surgery Patients Recurrence Recurrent pancreatic cancer Retrospective Studies S-1 Survival Rate Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Abstract Objectives A global consensus on how to treat recurrent pancreatic cancer after adjuvant chemotherapy with gemcitabine (ADJ-GEM) does not exist. Methods We retrospectively reviewed the clinical data of 41 patients with recurrences who were subsequently treated with chemotherapy. Results The patients were divided into two groups according to the time until recurrence after the completion of ADJ-GEM (ADJ-Rec): patients with an ADJ-Rec
ISSN:	1424-3903 1424-3911
DOI:	10.1016/j.pan.2012.07.016